Results 21 to 30 of about 1,064,868 (260)

GERMINE MONOACETATE COUNTERACTS DANTROLENE SODIUM [PDF]

open access: bronzeAnesthesiology, 1980
C. Lee   +3 more
openaire   +2 more sources

Discovery and Treatment of Action Potential-Independent Myotonia in Hyperkalemic Periodic Paralysis. [PDF]

open access: yesAnn Clin Transl Neurol
ABSTRACT Objective Hyperkalemic periodic paralysis (hyperKPP) is characterized by attacks of transient weakness. A subset of hyperKPP patients suffers from transient involuntary contraction of muscle (myotonia). The goal of this study was to determine mechanisms causing myotonia in hyperKPP.
Dupont C   +4 more
europepmc   +2 more sources

Postoperative Malignant Hyperthermia-A Medical Emergency: A Case Report and Review of Literature [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2017
Malignant hyperthermia is a rare life threatening pharmacological disorder. Preoperative clinical diagnosis is not possible. Due to its rarity and severity, it must be taken as an important differential diagnosis for postoperative hyperthermia.
Amit Kumar Sinha   +4 more
doaj   +1 more source

Malignant Hyperthermia Like Manifestations during Management of Refractory Status Epilepticus

open access: yesJournal of Neuroanaesthesiology and Critical Care, 2023
Management of refractory status epilepticus is challenging for a neurointensivist consequent to systemic complexities associated with various drugs and modalities involved in its treatment.
Deepti Srinivas   +3 more
doaj   +1 more source

Delayed-onset malignant hyperthermia in the postanesthetic care unit: a case report

open access: yesJournal of International Medical Research, 2021
Malignant hyperthermia (MH) is a potentially fatal hypermetabolic syndrome that occurs when susceptible individuals are exposed to triggering agents. Variability in the order and time of occurrence of symptoms often makes clinical diagnosis difficult.
Ji Young Min   +3 more
doaj   +1 more source

Hepatotoxicological Evaluation of Dantrolene Sodium [PDF]

open access: yesDrug and Chemical Toxicology, 1984
The clinical use of dantrolene has been associated with hepatotoxicity, thus the toxicity of dantrolene in Swiss-Webster mice was characterized. Animals were treated orally (po) with single or multiple doses of up to 400 mg/kg of D without any increases in SGPT or alterations in hepato-cellular architecture.
J A, Durham, A J, Gandolfi, J B, Bentley
openaire   +2 more sources

Early Recognition and Treatment of Malignant Hyperthermia in Pediatric Patient during Bronchoscopy

open access: yesCase Reports in Anesthesiology, 2020
Malignant hyperthermia is a rare pharmacogenetic disorder triggered by depolarizing muscle relaxant and potent volatile anesthetic agents. An MH crisis is an emergency and life-threatening event requiring early recognition and prompt management ...
Warangkana Lapisatepun   +1 more
doaj   +1 more source

Malignant Syndrome in Parkinson Disease Similar to Severe Infection [PDF]

open access: yesKorean Journal of Critical Care Medicine, 2017
A 70-year-old woman with Parkinson disease was admitted to the emergency department with altered consciousness, fever and convulsive movements without experiencing withdrawal from antiparkinsonian medication.
Dong Hun Lee   +2 more
doaj   +1 more source

Dantrolene sodium and dystrophia myotonica [PDF]

open access: yesAnaesthesia, 1984
Summary A patient with dystrophia myotonica was given dantrolene sodium to try to provide muscle relaxation during a cholecystectomy. Dantrolene was used as it is accepted that the drug has a place in the control of spasticity and also causes muscle relaxation, whereas conventional muscle relaxants are unable to control myotonia of ...
D C, Phillips   +3 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy